Search

Search Constraints

You searched for: Author/Creator Loirat, D

Search Results

1. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study. (26th November 2018)

2. Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages. (22nd May 2019)